Concepedia

Erich Tauber

ET

Statistics

Publications

29

Citations

2.3K

H-Index

23

Active since

1966

Affiliations

Intercell (Austria)(Current)

Vienna Biocenter

Medical University of Vienna

St Anna Children's Hospital

Children's Clinical University Hospital

Erich Tauber is an author at Intercell (Austria) specializing in immunology, infectious diseases, and vaccinology.

ORCID

Publications per year

1966–2023

29

Publications

29

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas et al. · The Lancet Infectious Diseases · 2015 · 233 citations

, , +11

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

Erich Tauber, Herwig Kollaritsch, Maria Korinek et al. · The Lancet · 2007 · 193 citations

, , +12

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler et al. · The Lancet · 2018 · 180 citations

, , +14

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Christoph Klade, Heiner Wedemeyer, Thomas Berg et al. · Gastroenterology · 2008 · 153 citations

, , +16

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

Samantha Brandler, Claude Ruffié, Chantal Combredet et al. · Vaccine · 2013 · 150 citations

, , +17

1–5 of 29